Search

AACR Project GENIE steering committee head and Chair of MSK’s Human Oncology and Pathogenesis Program, Dr. Charles Sawyers, discusses how the first batch of genomic sequencing data fulfills an unmet need in oncology.

… Wednesday, February 15, 2017 In early 2017 a global collaboration of eight cancer centers led by Memorial Sloan Kettering and coordinated by the American Association for Cancer Research (AACR), released its first batch of data: genomic sequencing information on tumors from over 19,000 cancer patients

Scientists have learned that a drug activates a form of highly inflammatory programmed cell death called pyroptosis — a discovery that sheds light on immune function.

… Monday, December 19, 2016 Summary A drug called Val-boroPro triggers an immune response against cancer in mice, but until now, researchers didn’t know the mechanism. The laboratory of Daniel Bachovchin at MSK discovered that Val-boroPro blocks two proteins, DPP8 and DPP9, causing a form of inflammatory

The risk of breast cancer increases as you age. MSK has breast cancer experts with special training and experience treating older patients.

… Thursday, September 7, 2023 When Vivian Moore was diagnosed with breast cancer at age 80, she worried how well she would tolerate the treatments. Living a full life, she was active in her church and busy with sewing, knitting, and sketching. She wanted to continue doing the things she loves. While some

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Wednesday, November 15, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the  annual list  of Highly Cited Researchers published by the 

The DNA breaks that occur during meiosis are necessary but dangerous. Scientists now have a better handle on how cells control the chaos.

… Wednesday, April 7, 2021 Sexual reproduction is like shuffling the genetic cards. Not only are you a blend of the genetic attributes of your parents, but the sperm and egg that came together to make you were themselves the product of a genetic shuffling called meiosis . Each time sperm and egg form from

Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.

… Thursday, March 18, 2021 Molecular biologist Agnel Sfeir studies how DNA is broken and repaired, and how these processes are related to aging, cancer, and other phenomena. A recent interest of hers is in the biology of the DNA inside of mitochondria — the “power plants” of the cell. She calls this DNA

The 2016 GSK Experimental Therapeutics Symposium will be held at MSKCC this fall in continuation of the former Med into Grad Program.

… Friday, September 23, 2016 The Experimental Therapeutics Symposium at Gerstner Sloan Kettering will take place September 30 th -October 1 st , bringing together PhD and MD-PhD students from former Howard Hughes Medical Institute Med into Grad grant recipient institutions. Conference attendees are participants

Melanie Steele, Director of Patient Financial Engagement at Memorial Sloan Kettering, answers key questions you might have about health insurance heading into 2021.

… Friday, October 16, 2020 Summary Melanie Steele, Director of Patient Financial Engagement at Memorial Sloan Kettering, answers key questions you might have about health insurance heading into 2021. Many Americans are facing changes to their health insurance this year. A sudden loss of income, moving

Research presented at the 2018 meeting of the American Society of Clinical Oncology showed that the relapse rate is low for melanoma patients treated with immunotherapy, but those who do relapse can respond a second time to immunotherapy. Dr. Chapman discusses the impact. (June 2018)

… Thursday, July 12, 2018

Memorial Sloan Kettering Cancer Center (MSK) announced that pediatric oncologist Richard Gilbertson, MBBS, PhD, of Cancer Research UK Cambridge Institute, has been named the 2022 recipient of The Society of Memorial Sloan Kettering Prize.

… Wednesday, May 18, 2022 Memorial Sloan Kettering Cancer Center (MSK) announced that pediatric oncologist Richard Gilbertson, MBBS, PhD , of Cancer Research UK Cambridge Institute, has been named the 2022 recipient of  The Society of Memorial Sloan Kettering Prize . The award was presented to Dr. Gilbertson